SOLISPHARM 2019 SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

TAX ID1133005528

KRS0000809637

Share capital5,000.00 zł

★ ★ ★ ★ ★ ★ ★ ★ ★ ★

No opinion. Add your first review

address

UL. TARGOWA 23 / 34, 03-728 WARSZAWA

Show on map

Is this your company?Update company information to get new customers, get notified of new reviews, and more!

Register Data

Full name

SOLISPHARM 2019 SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

uses securityreCAPTCHA

Privacy – Terms of Use

Legal address

UL. TARGOWA 23 / 34, 03-728 WARSZAWA

Show on map

NIP

1133005528

REGON

384682418

KRS

0000809637

Legal form

limited liability company

Register Address

UL. TARGOWA 23 / 34, 03-728 WARSZAWA

Date of registration in KRS

2019-10-22

Date of commencement of economic activity

2019-10-22

Act signature

WA.XIV NS-REJ.KRS/710/25/45/ADE

Pkd codes

49.41.Z - Road freight transport

47.74.Z - Retail sale of medical and orthopedic products

47.75.Z - Retail sale of cosmetics and toiletries

64.20 - Holding company activities and companies raising funds for other entities

70.10.Z - Head office activities

70.22.Z - Head office activities and management consultancy

73.11.Z - Advertising agency activities

73.12.C - Advertising through mass media

77.11.Z - Rental and leasing of passenger cars and light motor vehicles

81.21.Z - General cleaning of buildings

Company authorities

representation authorityMANAGEMENT

representation type

DO SKŁADANIA OŚWIADCZEŃ W IMIENIU SPÓŁKI JEST UPOWAŻNIONY KAŻDY Z CZŁONKÓW ZARZĄDU SAMODZIELNIE.

MANAGEMENT

Paweł Gajewski

Member Of The Board, 43 years old

Tomasz Marzewski

Member Of The Board, 40 years old

shareholders

Paweł Gajewski

50, 2500,00 pln

Tomasz Marzewski

50 udziałów o łącznej wartości 2500,00 złotych

Financial data

Net sales [PLN]

Gross profit / loss [PLN]

Automatically generated based on financial statements from KRS Registry

	2021	2022	2023
	M PLN	M PLN	M PLN	%
Gross profit (loss)	0,9	1,6	4,3	177,3
EBITDA	0,9	1,7	4,7	183,2
Short time liabilities	0,1	0,4	0,5	47,5
Equity capital	1,8	3,2	7	122,7
Operating profit (EBIT)	0,9	1,6	4,5	190,7
Assets	3,5	5,2	8,4	61,3
Net profit (loss)	0,8	1,4	3,9	175,1
Cash	0,2	0,2	0	-75,4
Net income from sale	1,8	3,5	7,4	110,4
Liabilities and provisions for liabilities	1,7	2,1	1,4	-32,3
Working assets	0,3	1	0,5	-51,2
Depreciation	0,1	0,1	0,2	65,3
	%	%	%	p.p.
Profitability of capital	44,4	44,6	55,1	10,5
Equity capital to total assets	50,4	60,4	83,4	23
Gross profit margin	48,2	44,2	58,3	14,1
EBITDA Margin	52	47,4	63,7	16,3
	Days	Days	Days	Days
Short term commitment turnover cycle	21	37	26	-11

Current financial liquidity indicator	2.6971137523651123	2.6812307834625244	0.8871315717697144	-1,8
Net dept to EBITDA	1.5713419914245605	0.9193643927574158	0.17687174677848816	-0,7